Cephalon, Mylan Drop Patents From Nuvigil Dispute
Cephalon Inc. and generic-drug company Mylan Pharmaceuticals Inc. have agreed to drop claims related to two of three patents involved an infringement suit over narcolepsy drug Nuvigil....To view the full article, register now.
Already a subscriber? Click here to view full article